Cite
HARVARD Citation
Todeschini, A. et al. (n.d.). P422 Transition from intravenous to subcutaneous infliximab and vedolizumab: adherence, satisfaction and safety profile in a cohort of patients with Inflammatory Bowel Disease. Journal of Crohn's and colitis. pp. i551-i552. [Online].